Advanced Biomed Inc. ADVB
6.38
0.07
1.11%
as of 25 Sep
- Market cap
- $10.4M
- P/E
- 1.3×
Follow ADVB
| Older periods | Jun '25 | Sep '25 | Dec '25 | Mar '26 | |
|---|---|---|---|---|---|
|
+6 more TTM periods Free account |
0.00% | (144.85%) | 86.84% | 79.17% | |
| (47.52%) | (108.29%) | 57.12% | 55.78% | ||
ROIC |
(309.33%) | (543.89%) | (28.55%) | (29.27%) | |
Return on Tangible Assets |
(99.71%) | (109.74%) | 45.80% | 57.47% | |
Free Cash Flow per Share |
(5.71) | (5.93) | (5.65) | (2.29) | |
Free Cash Flow |
(5.86) | (6.42) | (6.11) | (2.94) | |
Capital Expenditures |
(0.03) | (0.01) | (0.04) | (0.04) | |
Piotroski F-Score |
0.00 | 0.00 | 3.00 | 3.00 | |
| Other line items | |||||
Cash ROIC |
(91.81%) | (113.16%) | (50.28%) | (24.62%) | |
Accounts Payable Turnover |
— | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.79 | 1.90 | (1.39) | (0.55) | |
Depreciation/Fixed assets |
2.75 | 1.03 | 3.43 | 3.67 | |
Capex/Depreciation |
(0.09) | (0.05) | (0.11) | (0.11) | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(5.68) | (5.92) | (5.62) | (2.26) | |
Capex per Share |
(0.03) | (0.01) | (0.03) | (0.03) | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates